INTERNATIONAL PATENT: UMOJA BIOPHARMA, INC. FILES APPLICATION FOR "ENGINEERED INDUCED STEM CELL DERIVED MYELOID CELLS AND METHODS OF DIFFERENTIATING AND USING SAME"

GENEVA, June 25 -- UMOJA BIOPHARMA, INC. (1150 Eastlake Avenue East, Suite 400Seattle, WA 98109) filed a patent application (PCT/US2024/060149) for "ENGINEERED INDUCED STEM CELL DERIVED MYELOID CELLS AND METHODS OF DIFFERENTIATING AND USING SAME" on Dec 13, 2024. With publication no. WO/2025/129084, the details related to the patent application was published on Jun 19, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): JARRELL, Dillon (c/o Umoja Biopharma, Inc.1150 Eastlake Avenue East, Suite 400Seattle, WA 98109), KONING, Ryan (c/o Umoja Biopharma, Inc.1150 Eastlake Avenue East, Suite 400Seatt...